Biomarkers: Validation and Verification

The biomarker validation study represents a key step for the translation of the bench findings into clinical practice for tailored prescription or to accelerate the development of new drugs and other medical products. Biomarker validation is a multifaceted procedure that requires collaboration of multiple clinical centers and carries a significant financial burden and for which robust quantitative assays have been developed will enter the validation phase.

  • Biomarker validation
  • Biomarker identification

Related Conference of Biomarkers: Validation and Verification

July 28-29, 2025

45th Euro Congress on Cancer Science & Therapy

Paris, France
October 20-21, 2025

21st International Conference on Cancer Research

Barcelona, Spain
October 22-23, 2025

35th Experts Meet On Cancer Research & Therapy

Paris, France
October 24-25, 2025

25th World Congress on Cancer and Diagnostics

Zurich, Switzerland
November 20-21, 2025

26th World Congress on Cancer Summit

Amsterdam, Netherlands
November 24-25, 2025

43rd World Cancer Conference

Barcelona, Spain
December 08-09, 2025

13th Euro Breast Cancer and Therapeutics

Aix-en-Provence, France
February 19-20, 2026

7th Cancer Diagnostics & Treatment Conference

Miami, USA
February 19-20, 2026

8th International Conference on Women Oncology

Miami, USA
March 23-24, 2026

16th World Congress on Breast Cancer Research & Therapies

Aix-en-Provence, France

Biomarkers: Validation and Verification Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in